- Home
- QNRX vs AEMD Comparison
QNRX vs AEMD Comparison
Compare QNRX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- AEMD
- Stock Information
- Founded
- QNRX 2018
- AEMD 1984
- Country
- QNRX United States
- AEMD United States
- Employees
- QNRX N/A
- AEMD N/A
- Industry
- QNRX Medical/Dental Instruments
- AEMD Medical/Dental Instruments
- Sector
- QNRX Health Care
- AEMD Health Care
- Exchange
- QNRX Nasdaq
- AEMD Nasdaq
- Market Cap
- QNRX 4.4M
- AEMD 4.1M
- IPO Year
- QNRX N/A
- AEMD N/A
- Fundamental
- Price
- QNRX $7.36
- AEMD $0.77
- Analyst Decision
- QNRX
- AEMD Buy
- Analyst Count
- QNRX 0
- AEMD 2
- Target Price
- QNRX N/A
- AEMD $28.75
- AVG Volume (30 Days)
- QNRX 2.5K
- AEMD 8.9M
- Earning Date
- QNRX 11-06-2025
- AEMD 08-13-2025
- Dividend Yield
- QNRX N/A
- AEMD N/A
- EPS Growth
- QNRX N/A
- AEMD N/A
- EPS
- QNRX N/A
- AEMD N/A
- Revenue
- QNRX N/A
- AEMD N/A
- Revenue This Year
- QNRX N/A
- AEMD N/A
- Revenue Next Year
- QNRX N/A
- AEMD N/A
- P/E Ratio
- QNRX N/A
- AEMD N/A
- Revenue Growth
- QNRX N/A
- AEMD N/A
- 52 Week Low
- QNRX $5.01
- AEMD $0.60
- 52 Week High
- QNRX $54.95
- AEMD $8.44
- Technical
- Relative Strength Index (RSI)
- QNRX 46.17
- AEMD 39.96
- Support Level
- QNRX $7.37
- AEMD $0.60
- Resistance Level
- QNRX $7.79
- AEMD $0.82
- Average True Range (ATR)
- QNRX 0.14
- AEMD 0.20
- MACD
- QNRX 0.03
- AEMD -0.08
- Stochastic Oscillator
- QNRX 39.44
- AEMD 10.67
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.